Cargando…

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation

The aim of the study was to evaluate the impact of a decision aid (DA) and its timing in women being tested for a BRCA1/2 mutation. Women with and without a previous history of cancer were included after blood sampling for genetic testing. The DA consisted of a brochure and video providing informati...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Roosmalen, M S, Stalmeier, P F M, Verhoef, L C G, Hoekstra-Weebers, J E H M, Oosterwijk, J C, Hoogerbrugge, N, Moog, U, van Daal, W A J
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410151/ https://www.ncbi.nlm.nih.gov/pubmed/14735173 http://dx.doi.org/10.1038/sj.bjc.6601525

Ejemplares similares

Optimal selection for BRCA1 and BRCA2 mutation testing using a combination of ‘easy to apply’ probability models
por: Bodmer, D, et al.
Publicado: (2006)

Decision aids for second-line palliative chemotherapy: a randomised phase II multicentre trial
por: Oostendorp, Linda J. M., et al.
Publicado: (2017)

A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example
por: Mohammadi, Leila, et al.
Publicado: (2009)

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
por: Harmsen, Marline G., et al.
Publicado: (2017)

A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history
por: Gómez García, Encarna B, et al.
Publicado: (2009)

Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI
por: Veltman, J., et al.
Publicado: (2008)

Genome-wide scanning for linkage in 56 Dutch breast cancer families selected for a minimal probability of being due to BRCA1 or BRCA2
por: Oldenburg, RA, et al.
Publicado: (2005)

Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making
por: Reumkens, Kelly, et al.
Publicado: (2020)

Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers
por: van Egdom, L. S. E., et al.
Publicado: (2019)

Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2021)

Novel BRCA1 and BRCA2 Tumor Test as Basis for Treatment Decisions and Referral for Genetic Counselling of Patients with Ovarian Carcinomas
por: Weren, Robbert D.A., et al.
Publicado: (2016)

Balancing the presentation of information and options in patient decision aids: an updated review
por: Abhyankar, Purva, et al.
Publicado: (2013)

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
por: Krassuski, Lisa, et al.
Publicado: (2019)

Patient decision aids for patients with differentiated thyroid carcinoma: development process and alpha and beta testing
por: Koot, Anna, et al.
Publicado: (2023)

Decision aids for female BRCA mutation carriers: a scoping review protocol
por: McGarrigle, Sarah A, et al.
Publicado: (2021)

Is GP-led follow-up feasible?
por: Francken, A B, et al.
Publicado: (2010)

Quality of Life After Axillary or Groin Sentinel Lymph Node Biopsy, With or Without Completion Lymph Node Dissection, in Patients With Cutaneous Melanoma
por: de Vries, Mattijs, et al.
Publicado: (2009)

Which screening strategy should be offered to women with BRCA1 or BRCA2 mutations? A simulation of comparative cost-effectiveness
por: de Bock, G H, et al.
Publicado: (2013)

Assessing the information desire of patients with advanced cancer by providing information with a decision aid, which is evaluated in a randomized trial: a study protocol
por: Oostendorp, Linda JM, et al.
Publicado: (2011)

Delay in Diagnosis of Testicular Cancer; A Need for Awareness Programs
por: Öztürk, Çiğdem, et al.
Publicado: (2015)

The development of an online decision aid to support persons having a genetic predisposition to cancer and their partners during reproductive decision-making: a usability and pilot study
por: Reumkens, Kelly, et al.
Publicado: (2018)

The effect of a multifaceted empowerment strategy on decision making about the number of embryos transferred in in vitro fertilisation: randomised controlled trial
por: van Peperstraten, Arno, et al.
Publicado: (2010)

ASO Author Reflections: Stage-Adjusted Reduced Follow-Up of Melanoma Patients is Justified and Cost Effective, Until Biomarkers to Predict Prognosis Have Been Identified
por: Francken, Anne Brecht, et al.
Publicado: (2019)

Obesity is not associated with disease‐free interval, melanoma‐specific survival, or overall survival in patients with clinical stage IB‐II melanoma after SLNB
por: Deckers, Eric A., et al.
Publicado: (2021)

Temperament as a predictor of internalising and externalising problems in adolescent children of parents diagnosed with cancer
por: Visser, Annemieke, et al.
Publicado: (2006)

Introducing Decision Aids into Routine Prostate Cancer Care in The Netherlands: Implementation and Patient Evaluations from the Multi-regional JIPPA Initiative
por: Cuypers, Maarten, et al.
Publicado: (2019)

Finding all BRCA pathogenic mutation carriers: best practice models
por: Hoogerbrugge, Nicoline, et al.
Publicado: (2016)

Explanation and elaboration of the Standards for UNiversal reporting of patient Decision Aid Evaluations (SUNDAE) guidelines: examples of reporting SUNDAE items from patient decision aid evaluation literature
por: Hoffman, Aubri S, et al.
Publicado: (2018)

Development of an online patient decision aid for kidney failure treatment modality decisions
por: Engels, Noel, et al.
Publicado: (2022)

Providers’ perspectives on the reproductive decision-making of BRCA-positive women
por: Dason, E. S., et al.
Publicado: (2022)

Feasibility of implementing the ‘Screening for Distress and Referral Need’ process in 23 Dutch hospitals
por: van Nuenen, F. M., et al.
Publicado: (2016)

BRCA1-BARD1: the importance of being in shape
por: Daza-Martin, Manuel, et al.
Publicado: (2019)

The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status
por: C.E, Drechsel Katja, et al.
Publicado: (2022)

Online decision aid for patients with psoriasis
por: van der Kraaij, G.E., et al.
Publicado: (2021)

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI
por: Vreemann, Suzan, et al.
Publicado: (2018)

Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial
por: Visser, Annemiek, et al.
Publicado: (2011)

Development of a patient decision aid for discharge planning of hospitalized patients with stroke
por: Prick, J. C. M., et al.
Publicado: (2022)

Decision Aids for Preventive Treatment Alternatives for BRCA1/2 Mutation Carriers: a Systematic Review
por: Krassuski, Lisa Marlene, et al.
Publicado: (2021)

Decision aids for randomised controlled trials: a qualitative exploration of stakeholders’ views
por: Gillies, Katie, et al.
Publicado: (2014)

Cancer patients’ experiences with and opinions on the process 'Screening of Distress and Referral Need' (SDRN) in clinical practice: A quantitative observational clinical study
por: van Nuenen, Floor M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7vds95t3taidblovcu0s6sde2a